Pharmaceutical Regulatory Affairs And IPR
Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.
- Drug Safety of Biopharma products
- Regulatory Aspects
- Regulatory Affairs And IPR of Biopharma Products
Related Conference of Pharmaceutical Regulatory Affairs And IPR
Pharmaceutical Regulatory Affairs And IPR Conference Speakers
Recommended Sessions
- Bioequivalence Assessment
- Biologics and Biosimilars
- Biopharmaceuticals
- Biosimilars & Biologics: Clinical Studies & Trials
- Biosimilars & Biologics: Current Challenges
- Biosimilars Analytical Strategies
- Biosimilars: Pharmacovigilance and Safety
- Challenges in Biosimilars Pharmacovigilance
- Clinical Development Of Biosimilars
- Globalization of Biosimilars
- Innovation and Technology for Biosimilar Development
- Pharmaceutical Regulatory Affairs And IPR
- Regulatory Approach for Biosimilars
- Therapeutic Biological Products